Pimecrolimus 1% cream for oral erosive lichen planus: a 6-week randomized, double-blind, vehicle-controlled study with a 6-week open-label extension to assess efficacy and safety.
about
Medical Management of Oral Lichen Planus: A Systematic ReviewSite-specific immunosuppression in vascularized composite allotransplantation: prospects and potentialRelative efficacy of pimecrolimus cream and triamcinolone acetonide paste in the treatment of symptomatic oral lichen planusThe effect of pimecrolimus cream 1% compared with triamcinolone acetonide paste in treatment of atrophic-erosive oral lichen planus.Role of serum interleukin-6 in deciding therapy for multidrug resistant oral lichen planus.Efficacy of topical calcineurin inhibitors in lichen planus.Urban legends series: lichen planus.Novel therapies for oral lichen planus.Mucosal lichen planus: an evidence-based treatment update.Efficacy of Topical Calcineurin Inhibitors in Oral Lichen Planus.Interventions for the management of oral lichen planus: a review of the conventional and novel therapies.Pimecrolimus vs. tacrolimus for the topical treatment of unresponsive oral erosive lichen planus: a 8 week randomized double-blind controlled study.Anti-angiogenic therapy (bevacizumab) in the management of oral lichen planus.Microenvironmental regulation of the progression of oral potentially malignant disorders towards malignancy.Perspectives of Immune Suppression in the Tumor Microenvironment Promoting Oral Malignancy.
P2860
Q26752663-EAE2294D-747B-4165-9619-75DA6E5B6BD2Q27027795-455E2D66-301D-4D5E-A7E3-A450FCBF5A23Q35169829-B630719C-AB94-4D13-A5CA-AB386A6639D1Q35538692-65DCC7AA-E4BC-4999-87EE-BBCB4C9FFB8BQ36236612-5A7BAAE0-9590-4D55-A19C-BDA7D47FA4F2Q38025486-6AA1328F-F62F-4059-B643-3B162B5BA0CBQ38025689-6B306096-2D65-45CD-AF7A-66AD0579F6DFQ38106185-56D227D3-8C12-4210-A627-F37451F9C261Q38208232-4B8789C9-D529-4DE6-9AC9-F418179D004EQ38531564-7B78FBAE-80A1-4AE2-AF8A-1F774CCED7D7Q39038652-78C3A518-94F0-4546-969A-113E56E19F7FQ39459107-8E73E190-6C5F-4FDA-912E-9FEE8DB3C681Q39986140-0D426D20-0FE8-42E6-A128-2BE214499C0BQ43169264-A02C9026-2589-4FDA-A04E-13AC9A343D2AQ55511990-21C343E9-66D4-4D5D-9D68-265027C0B44D
P2860
Pimecrolimus 1% cream for oral erosive lichen planus: a 6-week randomized, double-blind, vehicle-controlled study with a 6-week open-label extension to assess efficacy and safety.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Pimecrolimus 1% cream for oral ...... to assess efficacy and safety.
@en
Pimecrolimus 1% cream for oral ...... to assess efficacy and safety.
@nl
type
label
Pimecrolimus 1% cream for oral ...... to assess efficacy and safety.
@en
Pimecrolimus 1% cream for oral ...... to assess efficacy and safety.
@nl
prefLabel
Pimecrolimus 1% cream for oral ...... to assess efficacy and safety.
@en
Pimecrolimus 1% cream for oral ...... to assess efficacy and safety.
@nl
P2093
P2860
P1476
Pimecrolimus 1% cream for oral ...... to assess efficacy and safety.
@en
P2093
P2860
P304
P356
10.1111/J.1468-3083.2010.03923.X
P577
2010-12-22T00:00:00Z